In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Broadvector Ltd.

www.broadvector.com.au

Latest From Broadvector Ltd.

Renewed Growth In Regenerative Medicine

Investments in regenerative medicine may finally be poised to deliver returns. Many therapies are finally moving into clinical trials. According to "Tissue Engineering and Cell Transplantation: U.S. Markets for Organ Regeneration Products," a report recently published by the Medtech Insight, several key clinical applications will create an almost $24 billion market by 2019.
Medical Device Platform Technologies

Deals Shaping the Medical Industry (11/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Start-Up Quarterly Statistics, Q3 2010

Biopharma, medical device, and in vitro diagnostics start-ups brought in a total of $780 million in Q3 2010, a 29% jump from the previous quarter and a 50% increase from Q3 2009. A total of eight start-up acquisitions closed in Q3, quite a jump from the first two quarters of 2010. The third quarter saw 14 biopharma alliances covering a wide range of therapeutic categories, the most popular indication being cancer.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Broadvector Ltd.
  • Senior Management
  • Andrew M Bray, PhD, Managing Dir. & CEO
    Malcolm J Booth, CFO
    Gerald W Both, PhD, CSO
  • Contact Info
  • Broadvector Ltd.
    Phone: (61) 3 9663 0035
    ANU House, Level 10
    52 Collins St.
    Melbourne, 3000
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register